HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 58 filers reported holding HOMOLOGY MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327 | +32.4% | 280 | 0.0% | 0.00% | – |
| Q2 2023 | $247 | -86.1% | 280 | -83.8% | 0.00% | – |
| Q1 2023 | $1,780 | +78.0% | 1,729 | +75.5% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 985 | +5.3% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 935 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -85.7% | 935 | -79.4% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 4,535 | +4.8% | 0.00% | – |
| Q4 2021 | $16,000 | -91.2% | 4,329 | -81.4% | 0.00% | – |
| Q3 2021 | $182,000 | +5.2% | 23,250 | -2.1% | 0.00% | – |
| Q2 2021 | $173,000 | -12.6% | 23,750 | +12.8% | 0.00% | – |
| Q1 2021 | $198,000 | -16.8% | 21,050 | -0.1% | 0.00% | -100.0% |
| Q4 2020 | $238,000 | +4.4% | 21,070 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -26.2% | 21,270 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $309,000 | -3.1% | 20,370 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $319,000 | – | 20,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
| Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
| AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
| Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
| Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
| PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
| American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
| Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
| FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |